CMV Vaccines
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,554,169 | CMV Vaccines In force · High confidence UsedRemaining | Hookipa Biotech GmbH | In force | High confidence | ||
| US 10,669,315 | HPV Vaccines In force · High confidence | AstraZeneca Ireland Limited | In force | High confidence | ||
| US 11,407,790 | HPV Vaccines In force · High confidence | AstraZeneca Ireland Limited | In force | High confidence | ||
| US 11,214,598 | Vaccines Against Hepatitis B Virus In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 11,266,727 | Arenavirus Particles as Cancer Vaccines In force · High confidence | AstraZeneca Ireland Limited | In force | High confidence | ||
| US 10,111,945 | CMV Vaccines Lapsed Oct 30, 2026 on the fee record Low confidence | Hookipa Biotech GmbH | Lapsed Oct 30, 2026 on the fee record | Low confidence | ||
| Application 16/302,086 | Tri-Segmented Pichinde Viruses as Vaccine Vectors Abandoned Abandoned Sep 28, 2022 | Gilead Sciences, Inc. | Abandoned | Abandoned Sep 28, 2022 | ||
| Application 16/347,501 | Replication-Deficient Arenavirus Particles and Tri-Segmented Arenavirus Particles as Cancer Vaccines Abandoned Abandoned Jul 10, 2024 | AstraZeneca Ireland Limited | Abandoned | Abandoned Jul 10, 2024 | ||
| Application 16/500,648 | Arenavirus Particles to Treat Solid Tumors Abandoned Abandoned Jul 9, 2024 | AstraZeneca Ireland Limited | Abandoned | Abandoned Jul 9, 2024 | ||
| Application 17/535,121 | Vaccines Against Hepatitis B Virus Abandoned Abandoned Sep 12, 2025 | Gilead Sciences, Inc. | Abandoned | Abandoned Sep 12, 2025 | ||
| 6 more records in this group · Pro | ||||||
10 of 16 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 16, including 1 expired.
1 of these is in force and held by Hookipa Biotech GmbH.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.